Review
Published on 09 Feb 2023
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1053814
- 20,538 views
- 11 citations
Type at least 3 characters
532 articles
Articles
Editorial
Published on 07 Feb 2023
Editorial: Model organisms in renal pharmacology: 2022
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1139806
- 891 views
Original Research
Published on 06 Feb 2023
Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1060464
- 5,026 views
- 2 citations
Review
Published on 06 Feb 2023
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1112088
- 6,999 views
- 4 citations
Review
Published on 03 Feb 2023
Protein arginine methyltransferases in renal development, injury, repair, and fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1123415
- 2,148 views
- 1 citation
Review
Published on 30 Jan 2023
Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1103062
- 5,291 views
- 10 citations
Original Research
Published on 17 Jan 2023
Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1082281
- 3,920 views
- 2 citations
Original Research
Published on 13 Jan 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1031790
- 1,958 views
- 2 citations
Original Research
Published on 09 Jan 2023
Prophylactic doxazosin reduces urinary retention and promotes recovery after total joint arthroplasty: A randomized controlled trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1016203
- 1,731 views
- 1 citation
Original Research
Published on 06 Jan 2023
Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1035755
- 2,838 views
- 4 citations
Original Research
Published on 30 Dec 2022
Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1069810
- 3,919 views
- 4 citations
Correction
Published on 22 Dec 2022
Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1074294
- 1,970 views
- 4 citations
Original Research
Published on 20 Dec 2022
Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.992597
- 2,955 views
- 2 citations
Original Research
Published on 07 Dec 2022
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1077047
- 1,494 views
Original Research
Published on 01 Dec 2022
Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.962770
- 2,117 views
- 3 citations
Original Research
Published on 29 Nov 2022
Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931670
- 3,695 views
- 3 citations